Literature DB >> 22189565

The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype.

Cécile Rouzier1, Sylvie Bannwarth, Annabelle Chaussenot, Arnaud Chevrollier, Annie Verschueren, Nathalie Bonello-Palot, Konstantina Fragaki, Aline Cano, Jean Pouget, Jean-François Pellissier, Vincent Procaccio, Brigitte Chabrol, Véronique Paquis-Flucklinger.   

Abstract

MFN2 and OPA1 genes encode two dynamin-like GTPase proteins involved in the fusion of the mitochondrial membrane. They have been associated with Charcot-Marie-Tooth disease type 2A and autosomal dominant optic atrophy, respectively. We report a large family with optic atrophy beginning in early childhood, associated with axonal neuropathy and mitochondrial myopathy in adult life. The clinical presentation looks like the autosomal dominant optic atrophy 'plus' phenotype linked to OPA1 mutations but is associated with a novel MFN2 missense mutation (c.629A>T, p.D210V). Multiple mitochondrial DNA deletions were found in skeletal muscle and this observation makes MFN2 a novel gene associated with 'mitochondrial DNA breakage' syndrome. Contrary to previous studies in patients with Charcot-Marie-Tooth disease type 2A, fibroblasts carrying the MFN2 mutation present with a respiratory chain deficiency, a fragmentation of the mitochondrial network and a significant reduction of MFN2 protein expression. Furthermore, we show for the first time that impaired mitochondrial fusion is responsible for a deficiency to repair stress-induced mitochondrial DNA damage. It is likely that defect in mitochondrial DNA repair is due to variability in repair protein content across the mitochondrial population and is at least partially responsible for mitochondrial DNA instability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189565     DOI: 10.1093/brain/awr323

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  89 in total

Review 1.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

Review 2.  The clinical maze of mitochondrial neurology.

Authors:  Salvatore DiMauro; Eric A Schon; Valerio Carelli; Michio Hirano
Journal:  Nat Rev Neurol       Date:  2013-07-09       Impact factor: 42.937

3.  Mitochondrial encephalomyopathies--fifty years on: the Robert Wartenberg Lecture.

Authors:  Salvatore DiMauro
Journal:  Neurology       Date:  2013-07-16       Impact factor: 9.910

4.  SSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder.

Authors:  Valentina Del Dotto; Farid Ullah; Ivano Di Meo; Pamela Magini; Mirjana Gusic; Alessandra Maresca; Leonardo Caporali; Flavia Palombo; Francesca Tagliavini; Evan Harris Baugh; Bertil Macao; Zsolt Szilagyi; Camille Peron; Margaret A Gustafson; Kamal Khan; Chiara La Morgia; Piero Barboni; Michele Carbonelli; Maria Lucia Valentino; Rocco Liguori; Vandana Shashi; Jennifer Sullivan; Shashi Nagaraj; Mays El-Dairi; Alessandro Iannaccone; Ioana Cutcutache; Enrico Bertini; Rosalba Carrozzo; Francesco Emma; Francesca Diomedi-Camassei; Claudia Zanna; Martin Armstrong; Matthew Page; Nicholas Stong; Sylvia Boesch; Robert Kopajtich; Saskia Wortmann; Wolfgang Sperl; Erica E Davis; William C Copeland; Marco Seri; Maria Falkenberg; Holger Prokisch; Nicholas Katsanis; Valeria Tiranti; Tommaso Pippucci; Valerio Carelli
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

5.  Neurologic Phenotypes Associated With Mutations in RTN4IP1 (OPA10) in Children and Young Adults.

Authors:  Majida Charif; Alessia Nasca; Kyle Thompson; Sylvie Gerber; Christine Makowski; Neda Mazaheri; Céline Bris; David Goudenège; Andrea Legati; Reza Maroofian; Gholamreza Shariati; Eleonora Lamantea; Sila Hopton; Anna Ardissone; Isabella Moroni; Melania Giannotta; Corinna Siegel; Tim M Strom; Holger Prokisch; Catherine Vignal-Clermont; Sabine Derrien; Xavier Zanlonghi; Josseline Kaplan; Christian P Hamel; Stephanie Leruez; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Frances E White; Steven A Hardy; Inês A Barbosa; Michael A Simpson; Roshni Vara; Yaumara Perdomo Trujillo; Hamind Galehdari; Charu Deshpande; Tobias B Haack; Jean-Michel Rozet; Robert W Taylor; Daniele Ghezzi; Patrizia Amati-Bonneau; Guy Lenaers
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

6.  Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.

Authors:  Emmanuelle C Genin; Sylvie Bannwarth; Françoise Lespinasse; Bernardo Ortega-Vila; Konstantina Fragaki; Kie Itoh; Elodie Villa; Sandra Lacas-Gervais; Manu Jokela; Mari Auranen; Emil Ylikallio; Alessandra Mauri-Crouzet; Henna Tyynismaa; Anna Vihola; Gaelle Augé; Charlotte Cochaud; Hiromi Sesaki; Jean-Ehrland Ricci; Bjarne Udd; Cristofol Vives-Bauza; Véronique Paquis-Flucklinger
Journal:  Neurobiol Dis       Date:  2018-08-06       Impact factor: 5.996

7.  Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model.

Authors:  Yueqin Zhou; Sharon Carmona; A K M G Muhammad; Shaughn Bell; Jesse Landeros; Michael Vazquez; Ritchie Ho; Antonietta Franco; Bin Lu; Gerald W Dorn; Shaomei Wang; Cathleen M Lutz; Robert H Baloh
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

8.  A novel MFN2 mutation causes variable clinical severity in a multi-generational CMT2 family.

Authors:  Lois Dankwa; Jessica Richardson; William W Motley; Mena Scavina; Steve Courel; Tanya Bardakjian; Stephan Züchner; Steven S Scherer
Journal:  Neuromuscul Disord       Date:  2018-12-21       Impact factor: 4.296

9.  Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.

Authors:  Stephan Klebe; Christel Depienne; Sylvie Gerber; Georges Challe; Mathieu Anheim; Perrine Charles; Estelle Fedirko; Elodie Lejeune; Julien Cottineau; Alfredo Brusco; Hélène Dollfus; Patrick F Chinnery; Cecilia Mancini; Xavier Ferrer; Guilhem Sole; Alain Destée; Jean-Michel Mayer; Bertrand Fontaine; Jérôme de Seze; Michel Clanet; Elisabeth Ollagnon; Philippe Busson; Cécile Cazeneuve; Giovanni Stevanin; Josseline Kaplan; Jean-Michel Rozet; Alexis Brice; Alexandra Durr
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

10.  Acquired Expression of Mutant Mitofusin 2 Causes Progressive Neurodegeneration and Abnormal Behavior.

Authors:  Kaori Ishikawa; Satoshi Yamamoto; Satoko Hattori; Naoya Nishimura; Haruna Tani; Takayuki Mito; Hirokazu Matsumoto; Tsuyoshi Miyakawa; Kazuto Nakada
Journal:  J Neurosci       Date:  2019-01-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.